Key details
- Programme typeOn campus open programme
- LocationOn campus
- Start dates7 Apr 2025 - Applications opening soon19 May 2025 - Applications opening soon8 Sept 2025 - Applications opening soon
- Duration1 week, full-time
- DepartmentLSE Health
Overview
Fast-track your understanding and develop highly competitive strategies for market access.
Gaining market access in the pharmaceutical industry is not easy. You need to secure effective and strategic decision-making across the entire product life cycle, as well as the cutting-edge strategies to adapt and pivot when necessary in a crowded and rapidly changing industry landscape. Importantly, you also need to reflect on how health systems are evolving and their growing concerns around efficiency, affordability and financial sustainability.
Working in conjunction with the Boston Consulting Group (BCG) and world-leading pharmaceutical companies from around the globe, LSE has created the Market Access Academy: a unique programme of bespoke lectures, workshops, illuminating case studies and distinguished guest speakers. Market Access Academy fully leverages our combined expertise and thought leadership to bring you advanced knowledge and insights, and the tools to read the market access environment, and devise the winning strategies to fully optimise access and value.
Impact
A transformational learning experience for you. Immediate impact for your organisation.
Programme content
Key topics:
How you learn
Market Access Academy is a unique and totally immersive learning experiences that seamlessly integrates theory, concept and practice. You will attend a bespoke schedule of highly developed programme of lectures, case studies, workshops, and notable guest speakers. This expertly tailored selection provides technical experts – as well as those from other functions – with a common grounding in the dynamics, trends, strategies and decision-making skills for market access.
View the provisional programme timetable below:
Join our mailing list
Sign up to get more information about Market Access Academy
Who attends?
Market Access Academy is tailored towards access new-starters as well as Senior Market Access delegates. Our target participant profiles are individuals who meet the following criteria:
- Minimum of 5 years' of experience post university - typically our participants have more than 10 years' work experience
- Leadership experience in other functions and looking to gain access exposure
- Limited or very specific access experience and looking to build the broader view
- Recently became or will become Global Access Leads in the near future.
"I would certainly recommend this programme to colleagues. It would be particularly valuable for colleagues who may not work in a policy or government affairs role, but who want to understand how they can contribute to positively shaping the external policy environment to increase access to medicines."
Why LSE?
At LSE, we understand the complex interconnectedness of the challenges facing our world. As Europe’s foremost social science university, we know that it is only by managing this interconnectedness that you can secure sustainability and success in business. All of our world-class programmes for leaders leverage the fullest benefits of our renowned, interdisciplinary expertise – the psychology, the finance, the economic dimensions, and the interplay between them that underscores global business. You emerge with the fully rounded understanding, the integrated mindset and the leading-edge strategic tools to navigate complexity and spearhead meaningful change.
Faculty
The programme is taught by:
Professor Elias Mossialos
Director LSE Health
Dr Panos Kanavos
Deputy Director of LSE Health
Professor Alistair McGuire
Professor of Health Economics at LSE Health and the Chair of LSE Health
Professor Allan Hackshaw
Professor of Epidemiology and Medical Statistics, CR UK & UCL Cancer Trials Centre
The Market Access Academy was founded by LSE in conjunction with the Boston Consulting Group and in partnership with AbbVie, AstraZeneca, Amgen, Bayer, Eli Lilly, Janssen, Merck, Pfizer, Roche, Sanofi, Takeda, UCB, and members of the BCG Market Access Roundtable. It is the first collaborative market access management development programme globally.
Department overview
LSE Health is a multidisciplinary research centre with over 20 years of experience in advancing global research in health policy and health economics. The centre's work is unique in its commitment to bridging the gap between research and policy worldwide. LSE Health promotes and draws upon the multidisciplinary expertise of 50 staff members, a significant number of affiliated academics, thriving community of postgraduate students, and a group of highly esteemed visitors.
Fees and entry requirements
Tuition fee 2024:
- Market Access Roundtable Members: £7,450
- Non Market Access Roundtable Members: £7,950
This covers all tuition, course materials, daily lunches and networking events. You will receive an LSE certificate of completion at the end of the course.
Entry requirements
All LSE executive education participants are required to have:
- Fluency in English, proficiency level or working knowledge of the language is essential
- Minimum of 5 years of experience post university (typically our participants have more than ten years’ work experience)
- Leadership experience in other functions looking to gain Access exposure
- Limited/or very specific Access experience and lack the broader view
- Recently became, or will become, Global Access Leads in the near future.
![A man having a discussion in a classroom](/exec-image-library/programme-page-images/Entrepreneurship-2.xb16fd8cf.png?format=webp&width=564&height=336&quality=100")
![A man sitting in a classroom](/exec-image-library/programme-page-images/lse-execs-2022-130.x6fe11503.jpg?format=webp&width=564&height=336&quality=100")
![A female executive looking to the front of the classroom](/exec-image-library/programme-page-images/ALE.xf53c71ae.png?format=webp&width=564&height=336&quality=100")